Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

Completed

Plain-English translation of NCT03315130 on ClinicalTrials.gov ↗ · Source last updated July 2022 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(30 sites)

United States

Diagnostic and Medical Clinic - Mobile, Mobile, Alabama

The Research Center of Southern California, Carlsbad, California

UCLA Medical Center, Los Angeles, California

University of California Irvine Health ALS and Neuromuscular Center, Orange, California

Yale University, New Haven, Connecticut